Schizophrenia Market Forecast

Published: October 2010
No. of Pages:

Price

Introduction

Despite imminent generic erosion of blockbuster brands, the schizophrenia market will retain its value, supported by the uptake of premium priced depot formulations and new pipeline therapies to offset the loss in sales revenue. Datamonitor forecasts the schizophrenia market to grow at a compound annual growth rate of 1.0% (2009-2019).

Features and benefits

Understand the country-specific impact of key events in the schizophrenia market during the forecast period 2010 to 2019.
Historic (2009) and future (2010-2019) sales dynamics of schizophrenia brands, generics, and pipeline agents.

Highlights

Despite the success of the atypical antipsychotics, several major unmet needs remain, including improved patient compliance, solutions for partial responders or treatment refractory patients, improved treatment of cognitive and negative symptoms and therapies with an enhanced side-effect profile.In the face of increasing cost constraints and competition in the schizophrenia market stemming from the genericization of atypical antipsychotics, Datamonitor does not expect new undifferentiated pipeline products to be positioned as first-line therapies or replicating the success of the current leading atypical antipsychotics.With current treatment options only exhibiting strong efficacy for positive symptoms, the opportunity remains for developers to address the lucrative patient population suffering from negative and cognitive impairment.

Your key questions answered

Whta is the current and future size of the schizophrenia market?
What are the potential licensing opportunities based on product portfolios and anticipated market needs?
What is the country-specific impact of key events in the schizophrenia market during the forecast period 2010 to 2019?

Please note: this is delivered as a Excel file.

Schizophrenia Market Forecast

N/A

Published By: Datamonitor
Product Code: Datamonitor10000

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:

Seroquel XR (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “ Seroquel XR (Schizophrenia)- Analysis and Forecasts to 2020” provides Seroquel XR sales estimates for US and EU5. In addi
Zyprexa (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, provides Zyprexa sales estimates for US, EU5 and Japan. In addition,
Seroquel (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, provides Seroquel sales estimates for US, EU5 and Japan. In additi
Saphris (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “Saphris (Schizophrenia) - Analysis and Forecasts to 2020” provides Saphris sales estimates for US and Japan. In addition, it
Risperdal (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, provides Risperdal sales estimates for US, EU5 and Japan. In add
Latuda (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, provides Latuda sales estimates for US, EU5 and Japan. In addition, it
Invega (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “Invega (Schizophrenia) - Analysis and Forecasts to 2020” provides Invega sales estimates for US and EU5 . In addition, it cove
Geodon/Zeldox (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “Geodon (Schizophrenia) - Analysis and Forecasts to 2020” provides Geodon sales estimates for US and EU5. In addition, i
Clozapine(Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “Clozapine (Schizophrenia) - Analysis and Forecasts to 2020” provides Clozapinesales estimates for US, EU5 and Japan. In addit
Abilify (Schizophrenia) - Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, provides Abilify sales estimates for US, EU5 and Japan. In addition

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option

Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: